Streptococcus pneumoniae Eradicates Preformed Staphylococcus aureus Biofilms through a Mechanism Requiring Physical Contact.
OA: gold
CC-BY-4.0
Abstract
Staphylococcus aureus (Sau) strains are a main cause of disease, including nosocomial infections which have been linked to the production of biofilms and the propagation of antibiotic resistance strains such as methicillin-resistant Staphylococcus aureus (MRSA). A previous study found that Streptococcus pneumoniae (Spn) strains kill planktonic cultures of Sau strains. In this work, we have further evaluated in detail the eradication of Sau biofilms and investigated ultrastructural interactions of the biofilmicidal effect. Spn strain D39, which produces the competence stimulating peptide 1 (CSP1), reduced Sau biofilms within 8 h of inoculation, while TIGR4, producing CSP2, eradicated Sau biofilms and planktonic cells within 4 h. Differences were not attributed to pherotypes as other Spn strains producing different pheromones eradicated Sau within 4 h. Experiments using Transwell devices, which physically separated both species growing in the same well, demonstrated that direct contact between Spn and Sau was required to efficiently eradicate Sau biofilms and biofilm-released planktonic cells. Physical contact-mediated killing of Sau was not related to production of hydrogen peroxide as an isogenic TIGR4ΔspxB mutant eradicated Sau bacteria within 4 h. Confocal micrographs confirmed eradication of Sau biofilms by TIGR4 and allowed us to visualize ultrastructural point of contacts between Sau and Spn. A time-course study further demonstrated spatial colocalization of Spn chains and Sau tetrads as early as 30 min post-inoculation (Pearson's coefficient >0.72). Finally, precolonized biofilms produced by Sau strain Newman, or MRSA strain USA300, were eradicated by mid-log phase cultures of washed TIGR4 bacteria within 2 h post-inoculation. In conclusion, Spn strains rapidly eradicate pre-colonized Sau aureus biofilms, including those formed by MRSA strains, by a mechanism(s) requiring bacterium-bacterium contact, but independent from the production of hydrogen peroxide.
My notes (saved in your browser only)
Funding
- funders
- [{'doi': '10.13039/100000002', 'name': 'National Institutes of Health', 'awards': ['R21AI112768-01A1']}]
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (31)
- doi:10.1084/jem.79.2.137 via crossref
- doi:10.1097/inf.0b013e318154b273 via crossref
- doi:10.1128/iai.65.4.1237-1244.1997 via crossref
- doi:10.1586/14787210.2015.1100533 via crossref
- doi:10.4049/jimmunol.76.2.89 via crossref
- doi:10.1016/s0140-6736(04)16357-5 via crossref
- doi:10.3389/fcimb.2014.00194 via crossref
- doi:10.1097/inf.0b013e318270d850 via crossref
- doi:10.1529/biophysj.103.038422 via crossref
- doi:10.1016/j.vaccine.2013.03.024 via crossref
- doi:10.1111/1469-0691.12752 via crossref
- doi:10.1073/pnas.0500879102 via crossref
- doi:10.1073/pnas.92.24.11140 via crossref
- doi:10.1111/j.1749-6632.2011.06281.x via crossref
- doi:10.1128/jb.01148-06 via crossref
- doi:10.1056/nejmoa1306801 via crossref
- doi:10.1128/jb.00950-08 via crossref
- doi:10.1186/1471-2180-10-59 via crossref
- doi:10.1128/jb.00006-08 via crossref
- doi:10.1046/j.1365-2958.1996.501417.x via crossref
- doi:10.1001/jama.292.6.716 via crossref
- doi:10.1128/jcm.01781-07 via crossref
- doi:10.1128/jb.00317-06 via crossref
- doi:10.1073/pnas.0809600106 via crossref
- doi:10.1371/journal.pone.0098829 via crossref
- doi:10.1016/j.tim.2012.11.005 via crossref
- doi:10.1128/jb.185.24.7176-7183.2003 via crossref
- doi:10.1126/science.1061217 via crossref
- doi:10.1128/iai.01096-12 via crossref
- doi:10.1128/iai.05186-11 via crossref
- doi:10.1128/jb.186.6.1838-1850.2004 via crossref
Source provenance
- crossref
- last seen: 2026-08-12T06:42:32.387478+00:00
- europepmc
- last seen: 2026-08-23T09:30:01.253652+00:00
License: CC-BY-4.0
· commercial use OK
· attribution required
Per Europe PMC
Per Europe PMC